|
p53 and p16 expression profiles reveal three prognostically relevant subgroups in vulvar cancer: A TMA based study by the AGO-CaRE-translational study group. |
|
|
Honoraria - GlaxoSmithKline; Jenapharm; Medac; MSD; OmniaMed; Prime Oncology; Roche; Tesaro |
Consulting or Advisory Role - Tesaro |
Research Funding - Greiner Bio-One (Inst); Medac (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Medac; Tesaro |
|
|
|
Other Relationship - Medac |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche Pharma AG; Tesaro |
Travel, Accommodations, Expenses - Tesaro |
|
|
Research Funding - Hologic |
Travel, Accommodations, Expenses - Intuitive Surgical |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Clovis Oncology; CRA International; Incyte; Roche Pharma AG; Seagen; Tesaro |
Consulting or Advisory Role - Clovis Oncology; CRA international; Roche Pharma AG; Seagen; Tesaro |
|
Travel, Accommodations, Expenses - AstraZeneca; Roche Pharma AG; Tesaro |
|
|
No Relationships to Disclose |
|
|
Honoraria - Roche; Tesaro |
Consulting or Advisory Role - Tesaro |
Travel, Accommodations, Expenses - Tesaro |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Roche |
|
|
No Relationships to Disclose |
|
|
|
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Roche |
|
|
Consulting or Advisory Role - MSD; Novartis Pharmaceuticals UK Ltd.; Roche; Tesaro |
Travel, Accommodations, Expenses - Medac |
|
|
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro |
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro |
|
|
No Relationships to Disclose |